Anna Franzén holds an MSc in Pharmaceutical Biosciences and a PhD in Toxicology from Uppsala University, Sweden. With over 20 years’ experience in the pharmaceutical industry, and regulatory environments such as the Swedish Medical Products Agency, Anna has developed a deep expertise in risk assessment, clinical research, and regulatory strategies. She has also worked extensively in industry-academic collaborations and start-ups, supporting the development of innovative healthcare solutions. Anna joined Emplicure in 2021 and leads the company’s clinical and regulatory strategy. Passionate about innovation and safety, she is dedicated to advancing novel solutions for nicotine and drug delivery.
